CN104027618A - Externally-applied traditional Chinese medicine for treating lupus erythematosus - Google Patents
Externally-applied traditional Chinese medicine for treating lupus erythematosus Download PDFInfo
- Publication number
- CN104027618A CN104027618A CN201410202768.7A CN201410202768A CN104027618A CN 104027618 A CN104027618 A CN 104027618A CN 201410202768 A CN201410202768 A CN 201410202768A CN 104027618 A CN104027618 A CN 104027618A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- lupus erythematosus
- chinese medicine
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A disclosed externally-applied traditional Chinese medicine for treating lupus erythematosus is composed of the raw materials in parts by weight: 2-4 parts of fructus kochiae, 5-6 parts of radix arnebiae, 4-6 parts of cortex moutan, 5-6 parts of radix saposhnikoviae, 2-4 parts of caulis spatholobi, 8-10 parts of broadbean seed-coat, 4-6 parts of radix clematidis, 2-4 parts of receptaculum nelumbinis, 10-12 parts of flos lonicerae, 4-6 parts of herba taraxaci, 8-10 parts of radix glycyrrhizae preparata, 1-3 parts of fructus liquidambaris, 2-4 parts of cornu bubali, 5-7 parts of adiantum capillus-veneris, 3-5 parts of spreading hedyotis herb, 2-4 parts of cynodon dactylon, 2-3 parts of glechoma longituba, 1-2 parts of lycianthes biflora, 1-3 parts of cymbopogon citratus and 2-3 parts of polygonum capitatum. Through scientific compatibility, mutual influence and synergic effect, the externally-applied traditional Chinese medicine gives play to extremely efficacy of clearing heart fire, cooling blood heat and releasing heat toxin, has extremely good treatment effect on lupus erythematosus, is safe and free of side effect, and also is simple in preparation method and convenient to administrate.
Description
technical field
The present invention relates to a kind of external application Chinese medicine for the treatment of lupus erythematosus, belong to the field of Chinese medicines.
Background technology
Lupus erythematosus (LE) is a kind of typical autoimmunity connective tissue disease, is more common in 15～40 years old women.Lupus erythematosus is a kind of disease spectrality disease, can be divided into the hypotypes such as discoid lupus erythematosus (DLE), subacute cutaneous lupus erythematosus (SCLE), systemic lupus erythematosus (sle) (SLE), lupus erythematosus profundus (LEP), neonatal lupus erythematosus (NLE), Drug lupus erythematosus (DIL); Lupus erythematosus there is no radical cure way at present, and a lot of needs of patients are treatment even all the life for a long time.Doctor trained in Western medicine is controlled the therapy that systemic lupus erythematosus (sle) adopts hormone more, hormone is controlled systemic lupus erythematosus (sle) and is had distinguished curative effect, but hormone has sizable side effect, and long-term a large amount of use hormone is unfavorable for patient's physical and mental health, moreover, subtracting of hormone stops very likely causing aggravation.
Summary of the invention
The object of the present invention is to provide a kind of external application Chinese medicine for the treatment of lupus erythematosus.
The present invention adopts following technical scheme to achieve these goals:
The external application Chinese medicine for the treatment of lupus erythematosus, the weight portion of its constitutive material is: Fructus Kochiae 2-4, Radix Arnebiae (Radix Lithospermi) 5-6, Cortex Moutan 4-6, Radix Saposhnikoviae 5-6, Caulis Spatholobi 2-4, Testa Viciae fabae 8-10, Radix Clematidis 4-6, lotus receptacle 2-4, Flos Lonicerae 10-12, Herba Taraxaci 4-6, Radix Glycyrrhizae Preparata 8-10, Fructus Liquidambaris 1-3, Cornu Bubali 2-4, venushair fern 5-7, Herba Hedyotidis Diffusae 3-5, Bermuda grass 2-4, HUOXUEDAN 2-3, ten calyx eggplant 1-2, Radix Cymbopogonis Citrati 1-3 and Herba Polygoni Capitati 2-3.
The external application Chinese medicine for the treatment of lupus erythematosus, the weight portion of its constitutive material is: the Fructus Kochiae 3, Radix Arnebiae (Radix Lithospermi) 5.5, Cortex Moutan 5, Radix Saposhnikoviae 5.5, Caulis Spatholobi 3, Testa Viciae fabae 9, Radix Clematidis 5, lotus receptacle 3, Flos Lonicerae 11, Herba Taraxaci 5, Radix Glycyrrhizae Preparata 9, Fructus Liquidambaris 2, Cornu Bubali 3, venushair fern 6, Herba Hedyotidis Diffusae 4, Bermuda grass 3, HUOXUEDAN 2.5, ten calyx eggplants 1.5, Radix Cymbopogonis Citrati 2 and Herba Polygoni Capitati 2.5.
Bermuda grass is the herb of grass Bermuda grass; HUOXUEDAN is the herb of labiate HUOXUEDAN; Ten calyx eggplants are Solanaceae Herba Peristrophis Roxburghianae platymiscium Flos Lonicerae Herba Peristrophis Roxburghianae, with leaf and Herb, are used as medicine, and have expelling phlegm for arresting cough, the effects such as heat-clearing and toxic substances removing; Herba Polygoni Capitati is the herb of polygonaceae plant Herba Polygoni Capitati.
Consumption and usage: by the weight portion of constitutive material, take each raw material, grind, then add vegetable oil to reconcile into pasty state, be coated on affected part, at every turn once, generally within 10-15 days, can cure.
Beneficial effect of the present invention:
External application Chinese medicine of the present invention, by science compatibility, influences each other, synergism, thus play good clearing away heart-fire, removing heat from blood heat, relieving heat toxin effect, lupus erythematosus disease is had to good therapeutic effect, and it has no side effect safely, preparation method is simple, and it is also convenient to take.
The specific embodiment
Embodiment 1: the external application Chinese medicine for the treatment of lupus erythematosus, the weight portion of its constitutive material (g) is: the Fructus Kochiae 3, Radix Arnebiae (Radix Lithospermi) 5.5, Cortex Moutan 5, Radix Saposhnikoviae 5.5, Caulis Spatholobi 3, Testa Viciae fabae 9, Radix Clematidis 5, lotus receptacle 3, Flos Lonicerae 11, Herba Taraxaci 5, Radix Glycyrrhizae Preparata 9, Fructus Liquidambaris 2, Cornu Bubali 3, venushair fern 6, Herba Hedyotidis Diffusae 4, Bermuda grass 3, HUOXUEDAN 2.5, ten calyx eggplants 1.5, Radix Cymbopogonis Citrati 2 and Herba Polygoni Capitati 2.5.
Consumption and usage: by the weight portion of constitutive material, take each raw material, grind, then add vegetable oil to reconcile into pasty state, be coated on affected part, at every turn once, generally within 10-15 days, can cure.
Model case:
Case 1, Huang, man, 54 years old, there is difform erythema at the positions such as face, helix and scalp, and shape erythema iris, edematous erythema etc., repeatedly utilize folk prescription or go to see a doctor, all to no effect, rear coating external application Chinese medicine of the present invention, once a day, applies after one week, skin skin bud treasure, erythema, pain relief, continue coating after one week, erythema disappears, and skin recovers as before.
Case 2, stone, man, 37 years old, upper breast, the back of the hand, forearm, lip had irregular shape erythema, and shape has erythema iris; Repeatedly go to see a doctor, all without remarkable result, rear coating external application Chinese medicine of the present invention, once a day, applies three days, skin nodules, and scorching hot pain, heating alleviate, and continue coating 10 days, cure, and it is normal that skin recovers.
Case 3, defend certain, female, 58 years old, the bridge of the nose, volume, auricle had irregular shape erythema, and shape has erythema iris and is mixed with arthralgia etc.; Apply external application Chinese medicine of the present invention, once a day, apply after one week, skin erythema, arthralgia alleviate, and continue coating after one week, cure.
Claims (2)
1. treat an external application Chinese medicine for lupus erythematosus, it is characterized in that the weight portion of its constitutive material is: Fructus Kochiae 2-4, Radix Arnebiae (Radix Lithospermi) 5-6, Cortex Moutan 4-6, Radix Saposhnikoviae 5-6, Caulis Spatholobi 2-4, Testa Viciae fabae 8-10, Radix Clematidis 4-6, lotus receptacle 2-4, Flos Lonicerae 10-12, Herba Taraxaci 4-6, Radix Glycyrrhizae Preparata 8-10, Fructus Liquidambaris 1-3, Cornu Bubali 2-4, venushair fern 5-7, Herba Hedyotidis Diffusae 3-5, Bermuda grass 2-4, HUOXUEDAN 2-3, ten calyx eggplant 1-2, Radix Cymbopogonis Citrati 1-3 and Herba Polygoni Capitati 2-3.
2. the external application Chinese medicine for the treatment of lupus erythematosus according to claim 1, is characterized in that the weight portion of its constitutive material is: the Fructus Kochiae 3, Radix Arnebiae (Radix Lithospermi) 5.5, Cortex Moutan 5, Radix Saposhnikoviae 5.5, Caulis Spatholobi 3, Testa Viciae fabae 9, Radix Clematidis 5, lotus receptacle 3, Flos Lonicerae 11, Herba Taraxaci 5, Radix Glycyrrhizae Preparata 9, Fructus Liquidambaris 2, Cornu Bubali 3, venushair fern 6, Herba Hedyotidis Diffusae 4, Bermuda grass 3, HUOXUEDAN 2.5, ten calyx eggplants 1.5, Radix Cymbopogonis Citrati 2 and Herba Polygoni Capitati 2.5.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410202768.7A CN104027618A (en) | 2014-05-15 | 2014-05-15 | Externally-applied traditional Chinese medicine for treating lupus erythematosus |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410202768.7A CN104027618A (en) | 2014-05-15 | 2014-05-15 | Externally-applied traditional Chinese medicine for treating lupus erythematosus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104027618A true CN104027618A (en) | 2014-09-10 |
Family
ID=51458763
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410202768.7A Pending CN104027618A (en) | 2014-05-15 | 2014-05-15 | Externally-applied traditional Chinese medicine for treating lupus erythematosus |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104027618A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105055646A (en) * | 2015-09-11 | 2015-11-18 | 耿文军 | Oral Chinese herba preparation for curing impetigo |
-
2014
- 2014-05-15 CN CN201410202768.7A patent/CN104027618A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105055646A (en) * | 2015-09-11 | 2015-11-18 | 耿文军 | Oral Chinese herba preparation for curing impetigo |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103611060A (en) | Traditional Chinese medicinal composition for treating scrofula | |
| CN103212021A (en) | Traditional Chinese medicine composition used for treating chloasma | |
| CN104906368A (en) | Traditional Chinese medicine composition for treating systemic lupus erythematosus | |
| CN103417774B (en) | Traditional Chinese medicine and preparing method and application thereof | |
| CN105012578A (en) | Traditional Chinese medicine composition for treating allergic rhinitis | |
| CN104027618A (en) | Externally-applied traditional Chinese medicine for treating lupus erythematosus | |
| CN104587046A (en) | Refreshing and moisturizing cream | |
| CN103191271A (en) | Preparation method of pain-alleviating and inflammation-diminishing ointment | |
| CN103007156B (en) | One treats anginal Chinese medicine decoction and preparation method thereof | |
| CN104257944A (en) | Externally-used traditional Chinese medicine for treating chilblain | |
| CN104922443A (en) | External-use patch for treating rheumatic arthritis | |
| CN105998862A (en) | Traditional Chinese medicinal composition for treating arthralgia and myalgia | |
| CN106620531A (en) | Traditional Chinese medicine composition for treating amenorrhea | |
| CN105770548A (en) | Externally-used traditional Chinese medicine for treating skin eczema | |
| CN105106706A (en) | Externally-used liniment for treating allergic dermatitis | |
| CN105148049A (en) | Traditional Chinese medicine decoction for treating irregular menstruation | |
| CN104958492A (en) | Traditional Chinese medicine composition for treating traumatic hemorrhage | |
| CN102743544A (en) | Traditional Chinese medicine for treating qi and blood stasis and obstruction type rheumatic arthralgia | |
| CN103610743B (en) | One treats phthisical external Chinese medicinal liquid | |
| CN104107297A (en) | Paste for treating intractable ulcer | |
| CN104127559A (en) | Medicinal liquor for treating rheumatic arthritis | |
| CN108837068A (en) | A kind of fire toxin hurts the Chinese medicine preparation and preparation method of arteries and veins psoriasis pustulosa treatment | |
| CN105998509A (en) | External-use traditional Chinese medicine for treating rheumatism bone pain | |
| CN105944007A (en) | TraditionalChinese medicine composition for treating traumatic injury | |
| CN105012606A (en) | External traditional Chinese medicine for treating soft tissue contusion |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20140910 |